Pulmonary embolism in a hemophiliac patient with factor V and VIII deficiency: a case report.


Journal

Journal of medical case reports
ISSN: 1752-1947
Titre abrégé: J Med Case Rep
Pays: England
ID NLM: 101293382

Informations de publication

Date de publication:
19 Oct 2024
Historique:
received: 11 03 2024
accepted: 15 09 2024
medline: 19 10 2024
pubmed: 19 10 2024
entrez: 18 10 2024
Statut: epublish

Résumé

This is an interesting and unexpected thromboembolic event in a hemophiliac patient. This is a case of a 33-year-old primigravidarum of Indian Asian origin with Factor V and Factor VIII deficiency who developed a case of pulmonary embolism during the course of her pregnancy after presenting to the emergency department in Leicester, United Kingdom, with hemoptysis, tachycardia, and tachypnea. Patient was subsequently diagnosed with pulmonary embolism after a computed tomography pulmonary angiogram and was treated with therapeutic daltaparin, a low-molecular-weight heparin. In conclusion, a thromboembolic event is not an improbable event in a hemophiliac patient and should be considered despite a low Well's score.

Sections du résumé

BACKGROUND BACKGROUND
This is an interesting and unexpected thromboembolic event in a hemophiliac patient.
CASE PRESENTATION METHODS
This is a case of a 33-year-old primigravidarum of Indian Asian origin with Factor V and Factor VIII deficiency who developed a case of pulmonary embolism during the course of her pregnancy after presenting to the emergency department in Leicester, United Kingdom, with hemoptysis, tachycardia, and tachypnea. Patient was subsequently diagnosed with pulmonary embolism after a computed tomography pulmonary angiogram and was treated with therapeutic daltaparin, a low-molecular-weight heparin.
CONCLUSION CONCLUSIONS
In conclusion, a thromboembolic event is not an improbable event in a hemophiliac patient and should be considered despite a low Well's score.

Identifiants

pubmed: 39425180
doi: 10.1186/s13256-024-04831-6
pii: 10.1186/s13256-024-04831-6
doi:

Substances chimiques

Heparin, Low-Molecular-Weight 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

481

Informations de copyright

© 2024. The Author(s).

Références

Pulmonary Embolism : What is it? (Last Revised in March 2022) NICE. Available at: https://cks.nice.org.uk/topics/pulmonary-embolism/background-information/definition/ Accessed 25 June 2023.
Spreafico M, Peyvandi F. Combined FV and FVIII deficiency. Haemophilia. 2008;14(6):1201–8. https://doi.org/10.1111/j.1365-2516.2008.01845.x .
doi: 10.1111/j.1365-2516.2008.01845.x pubmed: 19141160
Spreafico M, Peyvandi F. Combined factor V and factor VIII deficiency. Semin Thromb Hemost. 2009;35(4):390–9. https://doi.org/10.1055/s-0029-1225761 .
doi: 10.1055/s-0029-1225761 pubmed: 19598067
Royal College of Obstetricians and Gynaecologists. Developing a Green-top Guideline. London: RCOG; 2020.
Turpie AG, Chin BS, Lip GY. Venous thromboembolism: pathophysiology, clinical features, and prevention. BMJ. 2002;325(7369):887–90. https://doi.org/10.1136/bmj.325.7369.887 .
doi: 10.1136/bmj.325.7369.887 pubmed: 12386044 pmcid: 1124386
Davoodabadi A, Adib MM, Keleidari B. Post splenectomy fatal pulmonary embolism in a patient with moderate hemophilia a. Iran J Med Sci. 2011;36(2):136–40.
pubmed: 23358445 pmcid: 3556748
Aslam HM, Chong T, Park J, Nicolosi T, Shah R. Pulmonary Embolism in Acquired Hemophilia a: a rare complication with factor viii inhibitor bypassing activity therapy. Cureus. 2020;12(7): e9152. https://doi.org/10.7759/cureus.9152.
doi: 10.7759/cureus.9152. pubmed: 32789089 pmcid: 7417320
Wells PS, Anderson DR, Rodger M, Forgie M, Kearon C, Dreyer J, Kovacs G, Mitchell M, Lewandowski B, Kovacs MJ. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N Engl J Med. 2003;349(13):1227–35. https://doi.org/10.1056/NEJMoa023153 .
doi: 10.1056/NEJMoa023153 pubmed: 14507948
Le Gal G, Righini M, Roy PM, Sanchez O, Aujesky D, Bounameaux H, Perrier A. Prediction of pulmonary embolism in the emergency department: the revised Geneva score. Ann Intern Med. 2006;144(3):165–71. https://doi.org/10.7326/0003-4819-144-3-200602070-00004 .
doi: 10.7326/0003-4819-144-3-200602070-00004 pubmed: 16461960

Auteurs

Yap SuHao (Y)

Clinical Fellow in Obstetrics Anaesthetic Department, Leicester Royal Infirmary, Leicester, UK. suhao.yap@uhl-tr.nhs.uk.

Rajeev Vedantham (R)

Consultant anaesthetists, Leicester Royal Infirmary, Leicester, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH